Bortezomib for neuromyelitis optica spectrum disorder: a new therapeutic option for the more severe forms?
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
American Medical Association
2017
|
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
American Medical Association
2017
|